Pure Global AI
Italy flag

Italy medical device registration timeline

Source-linked clocks

Italian Ministry of Health (MoH) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Italy Medical Device Registration Process

Step-by-step MoH registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by MoH. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to MoH including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

MoH reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. MoH may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, MoH issues Italy market authorization certificate.

Summary: The Italy medical device registration process through Italian Ministry of Health (MoH) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Clinical investigation authorisation (class III, invasive IIa/IIb, Art. 74(2)): within 45 days of validation (+20 with experts) (Art. 16(2) D.Lgs. 137/2022)
  • Class I / non-invasive IIa/IIb: tacit start 30 days after validation absent rejection, with a favourable ethics opinion required
  • MDR Art. 59(1) derogation decided within 60 days (Art. 11(7)); IVDR Art. 54(1) likewise via Art. 8(6) D.Lgs. 138/2022
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Italy resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against MoH publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:italy:class-i